Resultados de la búsqueda 221-230 of 9220 for Birth Control Choices
... control (HC) donors. A Study to Compare Treatment With the Drug Selumetinib ... population. Patients will be enrolled over a three year period across ...
Fact sheet: Medications linked to falls. Centers for Disease Control and Prevention. · Poelgeest EP V, et al. Depression, antidepressants and fall risk: ...
... control (HC) donors. Alternate Doses and Dosing Schedules of Belantamab ... population. Patients will be enrolled over a three year period across ...
Thirty to 40 percent of people treated for GERD fail to respond to PPI therapy. The evaluation and management of these patients can be challenging. Research ...
To achieve this shorter course, proton therapy is used. This study aims to determine cancer control at 2 years after study registration. It also aims to ...
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
The purpose of the registry will be to support ongoing research in the etiology, early diagnosis, clinical management, and prognosis of lung cancer and other ...
This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...
... control (HC) donors. A Study to Evaluate Maximizing Anti-PD-1 Therapy By ... population. Patients will be enrolled over a three year period across ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?